Elicio Therapeutics ELTX
NASDAQ ELTX
$1.94 +0.27 (+16.17%)
At close: Oct 22, 2026 · 4:00 PM EDT

Elicio Therapeutics (ELTX) Amortization of Deferred Charges (2020 - 2026)

Updated

Analysis

Elicio Therapeutics (ELTX) Amortization of Deferred Charges (2020 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,144.36 Bn 1,112.95 Bn 19.71 Bn
2 Johnson & Johnson 635.36 Bn 555.22 Bn 17.30 Bn
3 AbbVie 502.79 Bn 475.90 Bn 12.70 Bn
4 Merck 356.08 Bn 310.46 Bn 12.21 Bn
5 Novartis Ag 300.87 Bn 264.86 Bn 11.24 Bn
6 Astrazeneca 264.31 Bn 237.99 Bn 12.86 Bn
7 Amgen 239.07 Bn 194.47 Bn 7.24 Bn
8 Gilead Sciences 194.50 Bn 168.70 Bn 6.22 Bn
9 Pfizer 171.00 Bn 117.64 Bn 10.94 Bn
10 Elicio Therapeutics 35.41 Mn -42.21 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 60,000.00
Mar 31, 2026 68,000.00
Dec 31, 2025 182,000.00
Mar 31, 2025 35,000.00
Dec 31, 2024 49,000.00
Sep 30, 2024 26,000.00
Mar 31, 2021 1.88 Mn
Dec 31, 2020 4.92 Mn
Sep 30, 2020 2.19 Mn
Jun 30, 2020 396,000.00
Mar 31, 2020 157,000.00
API Access

Elicio Therapeutics Amortization of Deferred Charges API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=amortization-of-deferred-charges&ticker=ELTX&period=max&api_key=YOUR_API_KEY